Thyroid nodules are common and are increasingly detected due to recent advances in imaging techniques. However, clinically relevant thyroid cancer is rare and the mortality from aggressive thyroid cancer remains constant. Fine needle aspiration cytology (FNAC) is a standard method for diagnosing thyroid malignancy and the discrimination of malignant nodules from goitre. As the examined nodules on thyroid FNAC are often small incidental findings, it is important to maintain a low rate of undetermined diagnoses requiring further clinical work up or surgery. The most important factors determining the accuracy of the cytological diagnosis and suitability for biobanking of thyroid FNACs are the quality of the sample and availability of adequate tissue for auxiliary studies. This article discusses technical aspects (preanalytics) of performing thyroid FNAC, including image guidance and rapid on-site evaluation, sample collection methods (conventional slides, liquid-based methods, cell blocks) and storage (bio-banking). The spectrum of special studies (immunocytochemistry on direct slides or liquid-based cytology, immunohistochemistry on cell blocks and molecular methods) required for improving the precision of the cytological diagnosis of the thyroid nodules is also discussed.
| INTRODUCTION
Thyroid nodules are common presentations of various thyroid diseases. 1, 2 The detection of thyroid masses, once mostly based on palpation, has now shifted to imaging studies, with frequent incidental findings. 3 Fine needle aspiration cytology (FNAC), introduced in 1970s, has proven to be the best method for assessing the nature and malignant potential of thyroid nodules. 4 Most thyroid nodules of all sizes correspond to benign goitre and do not need treatment unless they impinge on adjacent structures (eg, compressing the air- Specifically, the diagnostic criteria of follicular thyroid neoplasia are not based on cytological features, as in PTC and MTC, but rather on the architectural properties of the nodule capsule, which is not captured by FNAC. In such cases, an indeterminate cytological diagnosis of a follicular neoplasia (FN) is rendered, reflecting the fact that there is a 5%-30% risk of a malignant diagnosis on histological examination. The recently coined term, noninvasive follicular tumour with papillary-like features (NIFT-P), is not a new entity, but is rather an indolent, noninvasive subgroup of encapsulated follicular variants of papillary carcinoma. This nosological shift has forced cytopathologists to adjust the diagnostic criteria in their reports. 5 One of the most crucial aspects of thyroid cytology is the quality of the samples. The FNAC of thyroid nodules requires special skills, practice and deep understanding of the procedure and its aims. The failure to obtain good quality samples may lead to inaccurate diagnoses. In addition, poor quality specimens are not suitable for biobanking, since they will not provide useful biological information.
The introduction of standardised classification systems (four-to sixtiered) in the reporting of thyroid FNAC with stratification according to the estimated risk of malignancy, has contributed substantially to improvement in the understanding between cytopathologists and clinicians.
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The incidence of well-differentiated thyroid cancer, mainly small PTCs, has increased enormously in recent years, due to improved surveillance methods, including routine check-ups and imaging for other reasons. 11, 12 Many of these tumours, even if undetected, would probably never pose any clinical risks during the lifetime of the patients. 13, 14 Moreover, the prognosis of most differentiated thyroid cancer, even with local lymph nodes metastases, is excellent.
Advances in surgical techniques and nuclear medicine combined with the indolent biology of the disease contribute to the improved outcome. Mortality in thyroid cancer is seen mostly in patients with less well-differentiated or anaplastic thyroid cancer variants, and has remained constant for decades. The conclusion is that the detection and treatment of smaller nodules may not affect the development of aggressive thyroid cancer. 15 Overzealous detection of indolent thyroid nodules, especially combined with indeterminate cytological diagnosis, may lead to unnecessary surgeries with the potential risk of serious long-term complications in some patients. The growing understanding of the biology of the thyroid cancer and the current diagnostic procedures has led to modification of the guidelines for the selection of the nodules needing a FNAC. 4 Figures 1A and 2A) . 24, 25 The number of passes for a good-quality sample ranges from one to five, depending on the skills of the operator and on the properties of the studied lesion. 26 Sufficient cell content of a FNAC is the essential step to obtain useful and representative sample, which can not only be microscopically evaluated, but is also suitable for the application of ancillary techniques and storing in a biobank ( Figure 1 ).
| INTERVENTIONAL CYTOPATHOLOGY
The concept of the cytopathologist performing the FNAC (interventional cytopathology) is not new; however, the acceptance varies among different institutions and across medical specialties. [25] [26] [27] [28] FNAC is a low tech-high skills procedure, requiring experience and in- Cytopathologists benefit from the availability of high-quality material, which they have personally obtained and can focus on sorting out the differential diagnosis without distracting artefacts. Biobanking of thyroid cytology specimens in the setting of interventional cytopathology provides both high quality tissue, readily available clinical information, as well as access to histopathological diagnoses that can be used for research purposes. FNAC was repeated with rapid on-site evaluation. Clear chromatin was the predominant nuclear feature in an otherwise unremarkable follicular-patterned architecture (Diff-Quik® staining, ×400). As the previous FNAC diagnosis was atypia of undetermined significance/follicular lesion of undetermined significance, two additional passes were preformed to collect material for a cell block. (C) The cell block showed pseudo-papillary structures composed of cells with abundant cytoplasm and raisinoid nuclei, highly suspicious for papillary thyroid carcinoma. The provisional diagnosis was "suspicious for papillary thyroid carcinoma" (haematoxylin and eosin staining, ×400). Molecular analyses for the BRAF gene mutation (pyrosequencing) and RET gene rearrangement (fluorescence in situ hybridisation) were performed on the cell block and yielded evidence of a BRAF c.1799T>A (p.V600E) mutation, whereas a RET gene rearrangement was not detected. The final cytopathological diagnosis incorporating the molecular results was papillary thyroid carcinoma BODE-LESNIEWSKA ET AL.
| RAPID ON-SITE EVALUATION (ROSE)
Rapid
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The comparison of CSs to the LBC technique has been assessed in several studies. However, the results of the comparisons remain controversial, [32] [33] [34] [35] 
| CELL BLOCK (CB) PREPARATION
A cell block (CB) (or cytoblock) is a method of preparing cytological material so that it can be processed, sectioned, stained and viewed identical to histological specimen. CB provides additional architectural and morphological features and can be used as a source for supplementary histochemical, immunohistochemical and molecular biological studies (Figures 1,2,4) . 39, 40 It is important not to sacrifice the quantity or quality of the cytological slides in order to prepare a CB. 41 Thus, a CB is prepared using the material remaining after the cytology smears. There are different methods to prepare CB, some manual and in-house, others are automated, using industry-based applications/machines, previously reviewed in the literature. 39, 42 Briefly, CB can be prepared in 2 ways. 1) The aspirator places material directly into a preservative vial and then sends it to the cytopathology lab.
2) The aspirator prepares one or two smears after each pass and then rinses the syringe into the vial that can contain a preservative. The fixative can be PreservCyt, alcohol, formol or an acetic acid-based fixative. The sample is subsequently centrifuged and the pellet recovered according to different techniques. The most commonly used methods are plasma-thrombin, albumin and agar based. At the end of the process, the cells are embedded together with the plasma-thrombin, albumin or agar to form a soft aggregate that is fixed and can be further processed identically as a small biopsy. For fixation, the material can be fixed in 95% alcohol or in buffered formalin, according to laboratory preference. Using an automated process, 40 user variability is minimised, preparation time reduced but the cost is increased. Both alcohol and formalin fixation are possible with morphology and cellularity seem to be superior to traditional CB techniques. 40 For thyroid specimens, automated methods are preferable in the case of nondiagnostic and atypia of undetermined significance/follicular lesion of undetermined significance results, but yield little additional information in the case of low-cellularity specimens. 43 Importantly, immunocytochemical protocols for both manual and automated methods should be optimised and adapted for formalin or alcohol-fixed specimens. 44 CBs are useful not only for ancillary techniques but also as a source for molecular studies and long-term biobanking (Figures 1,2,4) . However, in the absence of a CB, biobanking of the smears is fundamental, since they provide alcohol-fixed cells that may (sometimes preferably) be used for prospective diagnostic and research purposes (see above).
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| LIQUID BASED CYTOLOGY (LBC)
The 
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The aspirated material is submerged in the haemolytic and With this technique, it is easy to avoid the artefacts previously described for CSs. The main advantage of this technique is convenience and simplicity in the handling of FNAC material as well as its suitability for the so called bad smear performers. Furthermore, the rapid transfer of cells into the vial offers optimal fixation and preservation ( Figure 5A , B, C) due to the alcohol-based fixatives, so that ancillary techniques may be applied without nucleic acids alteration.
| IMMUNOCYTOCHEMISTRY (ICC)
Immunocytochemistry ( have added RET, which is very specific for papillary carcinoma but less sensitive, Ki67 and TPO, which is a marker for well-differentiated cells. 57 Intense immunostaining for a majority of cells is highly suspicious of malignancy for all these markers except for TPO. For this latter marker, intense positivity of more than 80%-90% of follicular cells is a rule out immunostaining for malignancy. 58 More recent studies on the immunocytochemical detection of the protein associated with the BRAF V600E mutation using the antibody VE-1 on
FNACs specimen of the papillary thyroid carcinomas processed by LBC 59-61 ( Figure 5D ) or cell blocks 62 show a good correlation with the molecular testing results.
In 50% of cases, ICC enables reclassification of a follicular lesion of undetermined significance, a follicular neoplasm or a nodule suspicious for malignancy into a benign or malignant category, reducing the 20%-25% frequency of indeterminate lesions to 10%-15%. [56] [57] [58] Therefore, if molecular tests are not available, ICC may represent a helpful and cost-effective diagnostic alternative, for decision making between surgical resection and clinical monitoring. 
